Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-03-14
1993-04-20
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530307, 530317, A61K 3702, C07K 512, C07K 736
Patent
active
052043266
ABSTRACT:
Novel polypeptide derivatives, acid-addition salts thereof and complexes thereof, having the activities for inhibiting bone calcium absorption, for lowering the blood level of calcium, as analgesics, for inhibiting secretion of the gastric juice.
Pharmaceutical composition can be prepared by formulating, at least one of the novel polypeptide derivatives, acid-addition salts thereof and complexes thereof, together with a proteolytic enzyme inhibitors and/or pharmaceutically acceptable acids.
The pharmaceutical composition are quite effective as agents for curing hypercalcemia, for curing Peget's disease, for curing osteoporosis, analgetic agent, anti-ulcerative agent and the like.
REFERENCES:
patent: 4086221 (1978-04-01), Sakakibara et al.
patent: 4528132 (1985-07-01), Orlowski et al.
patent: 4597900 (1986-07-01), Orlowski et al.
patent: 4604236 (1986-08-01), Orlowski et al.
patent: 4605515 (1986-08-01), Orlowski et al.
patent: 4639511 (1987-01-01), Orlowski et al.
patent: 4703106 (1987-10-01), Hirose et al.
patent: 4758550 (1988-07-01), Cardinaux et al.
Fujii, deceased Setsuro
Fujii, successor by Keiko
Fujii, successor by Shinichiro
Hirohashi Mitsuru
Inai Masatoshi
Cashion Jr. Merrell C.
Marshall S. G.
Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Factory Inc.
LandOfFree
Polypeptide derivatives and calcium metabolism improving agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide derivatives and calcium metabolism improving agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide derivatives and calcium metabolism improving agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526170